Allopurinol Dosing for Prevention of Hyperuricemia in Patients Undergoing Chemotherapy

Dosing Considerations

The American Society of Clinical Oncology recommends allopurinol administration at 100 mg/m²/dose every 8 hours (10 mg/kg/day divided every 8 hours) orally with a maximum of 800 mg/day, or 200-400 mg/m²/day in 1-3 divided doses intravenously with a maximum of 600 mg/day for patients undergoing chemotherapy 1
Allopurinol should be started 1-2 days before initiating chemotherapy and continued for 3-7 days afterward, based on ongoing risk of tumor lysis syndrome (TLS) development 1
The dose of allopurinol should be reduced by at least 50% in patients with renal insufficiency, as recommended by clinical guidelines 1
For oral administration in high-risk TLS patients, the recommended dose is 100 mg/m² three times daily (maximum 800 mg/day) 3

Patients with high tumor burden (e.g., high-grade lymphomas, acute lymphoblastic leukemia) are considered high-risk for TLS, according to the European Hematology Association 3
Rasburicase is preferred over allopurinol for initial management of high-risk patients, as recommended by the American Society of Clinical Oncology 1, 3
After rasburicase treatment, transition to oral allopurinol for maintenance is recommended by clinical guidelines 3

The dose of 6-mercaptopurine and/or azathioprine should be reduced by 65-75% when used concomitantly with allopurinol, as recommended by the American Society of Clinical Oncology 1
Dose adjustments should be considered when allopurinol is used with dicumarol, thiazide diuretics, chlorpropamide, cyclosporine, or cytotoxic agents, according to clinical guidelines 1, 2

Serum uric acid, electrolytes (potassium, phosphate, calcium), and renal function should be monitored every 12 hours for the first three days, then every 24 hours, as recommended by the European Hematology Association 3
The risk of xanthine crystal deposition in renal tubules, which can cause acute obstructive uropathy, should be considered when using allopurinol, according to clinical guidelines 1

Hydration should be started at least 48 hours before chemotherapy when possible, with a goal of maintaining urine output of at least 100 mL/hour in adults (3 mL/kg/hour in children <10 kg), as recommended by the European Hematology Association 3

Allopurinol should not be administered concurrently with rasburicase to avoid xanthine accumulation and lack of substrate for rasburicase, as recommended by clinical guidelines 3
In patients with G6PD deficiency, allopurinol should be used with hydration and urine alkalinization, according to the European Hematology Association 3
For patients with preexisting hyperuricemia (>7.5 mg/dL), rasburicase is preferred over allopurinol, as recommended by the American Society of Clinical Oncology 1